| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |